This legislation aims to reform the 340B drug pricing program, which enables certain healthcare providers to purchase medications at discounted rates for low-income patients. The primary goals are to enhance the program's effectiveness, ensure that patients benefit from these discounts, and maintain the program's integrity. Key provisions include stricter definitions of patient eligibility, requiring that only individuals with a direct relationship to a covered entity can access discounted drugs.